期刊文献+

铜绿假单胞菌异质性耐药的研究进展 被引量:4

Research progress on heteroresistance of Pseudomonas aeruginosa
原文传递
导出
摘要 异质性耐药是指细菌中的同源亚群对某种抗生素表现出不同的敏感性,被认为是细菌由敏感进化成完全耐药的中间阶段。常规的临床检验无法有效检测出异质性耐药,这对临床治疗用药造成了巨大的威胁,引起患者的反复感染和用药失败。铜绿假单胞菌作为医院内感染的主要条件致病菌之一,其耐药机制已被广泛研究,而异质性耐药研究则相对较少。本文主要就铜绿假单胞菌的异质性耐药研究进行了梳理,并对异质性耐药从表型特征、机制和检测方法等方面进行了简要阐明。 Heteroresistance refers to the different susceptibilities of homologous bacterial subgroups to an antibiotic,which is considered as the intermediate stage of bacterial evolution from susceptibility to resistance.Conventional clinical tests cannot effectively detect heteroresistance,which poses a serious threat to clinical treatment and medication,resulting in repeated infection and medication failure of patients.Pseudomonas aeruginosa is one of the main opportunistic pathogens causing nosocomial infection.Despite the extensive research on the drug resistance mechanism of P.aeruginosa,the studies about the heteroresistance of this bacterium are rare.In this review,we summarized the related studies about the heteroresistance of P.aeruginosa and expounded the phenotypic characteristics,mechanism,and detection methods of heteroresistance.
作者 张亚会 李文茹 谢小保 ZHANG Yahui;LI Wenru;XIE Xiaobao(Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application,State Key Laboratoryof Applied Microbiology Southern China,Institute of Microbiology,Guangdong Academy of Sciences,Guangzhou 510070,Guangdong,China;Zhejiang Ocean University,Zhoushan 316022,Zhejiang,China)
出处 《微生物学通报》 CAS CSCD 北大核心 2022年第3期1167-1176,共10页 Microbiology China
基金 广东省基础与应用基础研究基金(2021A1515011080,2020A1515010850)。
关键词 铜绿假单胞菌 异质性耐药 生物膜 Pseudomonas aeruginosa heteroresistance biofilm
  • 相关文献

参考文献7

二级参考文献39

  • 1Martinez M , Lopez o Ribot JL. Heterogeneous mecha nisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis[J]. J Antimicrob Chemother, 2002,49 (3): 515-524.
  • 2Chesneau O , Morvan A , Solh NEI . Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals[J]. J Antimicrob. Chemother, 2000,45(6):887-890.
  • 3Susan Boyle - Vavra , Sarah KB. Reversion of the gly -copeptide resistance phenotype in Staphylococcus aureus clinical isolates[J]. Antimicrob Agents Chemother,2000,44(2) :272-277.
  • 4Theresa L, Smith. Emergence of ancomycin resistance in Staphylococcus aureus[J]. N Engl J Med, 1999,340(7) :493-501.
  • 5Hiramatsu K,Hanaki H,Ino T ,et al. Methicillin-resistant staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J]. J Antimicrob chemother,1997,40(1): 135-136.
  • 6Nanae A,Hideaki H. Combination effect of vancomycin and β-lactams against a Staphylococcus aureus strain Mu3,with heterogeneous resistance to vancomycin[J].Antimicrobial Agents and Chemother, 2001, 45 (4) :1292-1294.
  • 7Wootton M,Howe RA. A modified population analysis profile (PAP)method to vancomycin in staphylococcus aureus in a UK hospital[J]. J Antimicrob Chemother,2001,47(4) :399-403.
  • 8Mainardi JL, Shales DM,Goering RV,et al. Decreased teicoplanin susceptibility of methicillin resistant of staphylococcus aureus[J]. J Infect Dis, 1995, 171 (6):1646-1680.
  • 9Ryffel C,Strassle A. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus[J]. Antimicrobial Agents and Chemotherapy, 1994, 38 (4): 724-728.
  • 10Stranden AM, Roos M. Glutamine synthetase and heteroresistance in methicillin-resistant Staphylococcus aureus[J]. Microb Drug Resist, 1996,2 (2) : 201-207.

共引文献1097

同被引文献27

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部